Drug Profile


Alternative Names: Aviva; DUP 996; Linopirine

Latest Information Update: 18 Jan 1996

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bristol-Myers Squibb
  • Class Indoles; Neuroprotectants; Nootropics; Pyridines; Small molecules
  • Mechanism of Action Acetylcholine stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Alzheimer's disease

Most Recent Events

  • 18 Jan 1996 An in vitro study has been added to the pharmacodynamics section
  • 13 Feb 1995 Discontinued-I for Alzheimer's disease in Austria (PO)
  • 13 Feb 1995 Discontinued-I for Alzheimer's disease in Ireland (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top